Drug Shortage Report for NOZINAN
| Report ID | 113622 |
| Drug Identification Number | 01927698 |
| Brand name | NOZINAN INJ 25MG/ML |
| Common or Proper name | Nozinan Inj 25mg/ml |
| Company Name | NEURAXPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | METHOTRIMEPRAZINE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10 |
| ATC code | N05AA |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2020-05-01 |
| Actual start date | |
| Estimated end date | 2020-05-15 |
| Actual end date | 2020-05-04 |
| Shortage status | Resolved |
| Updated date | 2020-05-05 |
| Company comments | Missing required documentation for product release from manufacturing site The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ELISABETH-SELBERT-STR. 23 LANGENFELD, GERMANY 40764 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-05-05 | English | Compare |
| v7 | 2020-05-04 | French | Compare |
| v6 | 2020-05-04 | English | Compare |
| v5 | 2020-05-02 | English | Compare |
| v4 | 2020-05-01 | French | Compare |
| v3 | 2020-05-01 | English | Compare |
| v2 | 2020-05-01 | French | Compare |
| v1 | 2020-05-01 | English | Compare |
Showing 1 to 8 of 8